Literature DB >> 29268951

Effective treatment of restless legs syndrome by safinamide in Parkinson's disease patients.

Claudio Liguori1, Nicola Biagio Mercuri2, Alessandro Stefani3, Mariangela Pierantozzi3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29268951     DOI： 10.1016/j.sleep.2017.09.017

Source DB:  PubMed          Journal:  Sleep Med        ISSN： 1389-9457            Impact factor:   3.492


× No keyword cloud information.
  6 in total

Review 1.  Pharmacological and Non-pharmacological Treatments of Sleep Disorders in Parkinson's Disease.

Authors:  Reyisha Taximaimaiti; Xingguang Luo; Xiao-Ping Wang
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.708

2.  Safinamide in Clinical Practice: A Spanish Multicenter Cohort Study.

Authors:  Gloria Martí-Andrés; Rayco Jiménez-Bolaños; José Matias Arbelo-González; Javier Pagonabarraga; Carmen Duran-Herrera; Rafael Valenti-Azcarate; Mª Rosario Luquin
Journal:  Brain Sci       Date:  2019-10-11

3.  Non-motor symptoms burden in motor-fluctuating patients with Parkinson's disease may be alleviated by safinamide: the VALE-SAFI study.

Authors:  Claudia De Masi; Claudio Liguori; Matteo Spanetta; Mariana Fernandes; Rocco Cerroni; Elena Garasto; Mariangela Pierantozzi; Nicola Biagio Mercuri; Alessandro Stefani
Journal:  J Neural Transm (Vienna)       Date:  2022-09-07       Impact factor: 3.850

Review 4.  A Spanish Consensus on the Use of Safinamide for Parkinson's Disease in Clinical Practice.

Authors:  Javier Pagonabarraga; José Matías Arbelo; Francisco Grandas; Maria-Rosario Luquin; Pablo Martínez Martín; Mari Cruz Rodríguez-Oroz; Francesc Valldeoriola; Jaime Kulisevsky
Journal:  Brain Sci       Date:  2020-03-18

5.  Safinamide Improves Non-Motor Symptoms Burden in Parkinson's Disease: An Open-Label Prospective Study.

Authors:  Diego Santos García; Carmen Labandeira Guerra; Rosa Yáñez Baña; Maria Icíar Cimas Hernando; Iria Cabo López; Jose Manuel Paz Gonález; Maria Gemma Alonso Losada; María José González Palmás; Cristina Martínez Miró
Journal:  Brain Sci       Date:  2021-03-02

Review 6.  Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future.

Authors:  Yu-Yan Tan; Peter Jenner; Sheng-Di Chen
Journal:  J Parkinsons Dis       Date:  2022       Impact factor: 5.568
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.